In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHA Biotech Co. Ltd.

www.chabio.com

Latest From CHA Biotech Co. Ltd.

Nature Cell’s Stem Cell Alzheimer’s Therapy Advances Amid Failures

Nature Cell is set to begin a groundbreaking clinical trial in the US of a novel autologous stem cell therapy for Alzheimer's disease, a new approach likely to gain attention amid other high profile failures in the challenging indication.

Research & Development Neurology

Deals Shaping the Medical Industry, September 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2016.

Deals BioPharmaceutical

CHA, Sorrento JV Highlights Korean Immuno-Oncology Appetite

Sorrento and CHA Biotech’s agreement to form a CAR-NK cell therapy joint venture is very much “on trend”, being the latest in a recent series of immuno-oncology collaborations between Korean and foreign firms and indicating a rapidly growing appetite for assets in the field.

Research & Development Deals

Biostar, Kangstem Expand Stem Cell Therapy Pipelines Into AD, Psoriasis

Biostar Group and Kangstem Biotech are expanding their stem cell therapy pipelines via additional indications and a joint development deal, marking a further expansion of South Korea’s activities in the field into the new areas of Alzheimer’s and psoriasis.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • CHA Biotech Co. Ltd.
  • Senior Management
  • Jong-soo Choi, CEO
  • Contact Info
  • CHA Biotech Co. Ltd.
    Phone: (82) 31 881 7400
    Vision Bldg., 1st Fl.
    Yeoksam-dong
    Seoul, 606-16
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register